A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
iOnctura
iOnctura
Ipsen
Ipsen
Taproot Health
Ascentage Pharma Group Inc.
Eli Lilly and Company
Incyte Corporation
Curis, Inc.
Shenzhen BinDeBio Ltd.
Novartis
Novartis
Valerio Therapeutics